Charles Schwab Investment Management Inc Harvard Bioscience Inc Transaction History

Charles Schwab Investment Management Inc

  • $521 Billion
  • Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 98,883 shares of HBIO stock, worth $32,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,883
Previous 239,696 58.75%
Holding current value
$32,631
Previous $505,000 88.91%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$0.57 - $2.19 $80,263 - $308,380
-140,813 Reduced 58.75%
98,883 $56,000
Q2 2024

Aug 12, 2024
BUY
$2.77 - $4.63 $27,470 - $45,915
9,917 Added 4.32%
239,696 $683,000
Q1 2024

May 08, 2024
SELL
$4.02 - $5.39 $27,729 - $37,180
-6,898 Reduced 2.91%
229,779 $974,000
Q3 2023

Nov 08, 2023
BUY
$4.0 - $5.82 $25,748 - $37,463
6,437 Added 2.8%
236,677 $1.02 Million
Q2 2023

Aug 09, 2023
BUY
$4.19 - $6.16 $330,582 - $486,011
78,898 Added 52.13%
230,240 $1.26 Million
Q4 2022

Feb 13, 2023
SELL
$2.12 - $2.86 $96,360 - $129,995
-45,453 Reduced 23.1%
151,342 $419,000
Q2 2022

Aug 15, 2022
SELL
$3.28 - $6.42 $227,622 - $445,528
-69,397 Reduced 26.07%
196,795 $709,000
Q1 2022

May 13, 2022
BUY
$5.16 - $7.14 $290,616 - $402,131
56,321 Added 26.84%
266,192 $1.65 Million
Q3 2021

Nov 16, 2021
BUY
$6.98 - $8.47 $22,447 - $27,239
3,216 Added 1.56%
209,871 $1.47 Million
Q2 2021

Aug 16, 2021
BUY
$5.44 - $8.4 $604,759 - $933,819
111,169 Added 116.42%
206,655 $1.72 Million
Q1 2021

May 17, 2021
BUY
$3.91 - $6.99 $27,205 - $48,636
6,958 Added 7.86%
95,486 $522,000
Q2 2020

Aug 14, 2020
BUY
$2.12 - $3.14 $187,679 - $277,977
88,528 New
88,528 $275,000
Q4 2019

Feb 07, 2020
SELL
$2.45 - $3.25 $268,069 - $355,602
-109,416 Closed
0 $0
Q2 2019

Aug 09, 2019
BUY
$1.93 - $4.59 $66,100 - $157,202
34,249 Added 45.56%
109,416 $219,000
Q1 2019

May 14, 2019
SELL
$2.77 - $4.38 $26,938 - $42,595
-9,725 Reduced 11.46%
75,167 $324,000
Q3 2018

Nov 13, 2018
BUY
$5.0 - $6.65 $81,500 - $108,395
16,300 Added 23.76%
84,892 $446,000
Q2 2018

Aug 08, 2018
BUY
$4.2 - $5.95 $207,026 - $293,287
49,292 Added 255.4%
68,592 $367,000
Q3 2017

Nov 13, 2017
BUY
$2.7 - $3.75 $52,110 - $72,375
19,300
19,300 $73,000

Others Institutions Holding HBIO

# of Institutions
96
Shares Held
26.2M
Call Options Held
8.7K
Put Options Held
2K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $13.7M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email